Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- 10 Nov 2020
- Sharpening Your Skills
Research News and Tips: Innovating Across Time Zones
Dany Bahar, Prithwiraj Choudhury, and Britta Glennon. Drugs approved in December are associated with more adverse effects New research reveals that drug approvals surge in the US in December, at month-ends,... View Details
Keywords: by Sean Silverthorne
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC [over-the-counter] sector, they... View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers association, Frazier has led the... View Details
Keywords: by Bill George
- 28 Oct 2014
- First Look
First Look: October 28
disruptive to its drug development efforts and delay new drugs coming to market. UK politicians expressed concerns over downsizing and job losses in the economically important pharmaceutical sector. The case... View Details
Keywords: Carmen Nobel
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the 1990s, the U.S. and European... View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients, expectations were high, with some... View Details
Keywords: Sean Silverthorne
- 09 Sep 2014
- First Look
First Look: September 9
patient. Schrader and his colleagues had to decide on which vaccines to focus and whether and how to target the drug companies that manufactured the vaccines or the quasi-government organizations (such as UNICEF and PAHO) and... View Details
Keywords: Sean Silverthorne
- 27 Mar 2012
- First Look
First Look: March 27
services will become its key competitive advantage in the decade to come. This case traces the evolution of the CRO sector from a small, secondary cluster of firms into a major player with essential capabilities for global drug... View Details
Keywords: Carmen Nobel
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 02 Sep 2008
- First Look
First Look: September 3, 2008
Note on Generic Drugs in the European Union Harvard Business School Note 309-019 Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of... View Details
Keywords: Sean Silverthorne
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
American manufacturer of antibiotics—those life-saving drugs required for pneumonia caused by COVID-19—as others have abandoned them to pursue more lucrative drugs. Frazier elected to stay in the business because he knows how essential... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill costs 5 cents to manufacture,... View Details
Keywords: by Max H. Bazerman
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
South Africa over its attempt to reduce the cost of HIV drugs through parallel importation (buying pharmaceuticals in countries with lower prices and then importing them) and compulsory licensing (requiring patent holders to allow others... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
problems that were posted? A: Innovations happen at the intersection of disciplines. People have talked about that a lot and I think we're providing some systematic evidence now with this study. Another example is that a pharmaceutical company got unusual toxicology... View Details
Keywords: by Martha Lagace
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
process of testing drugs and bringing them to market. No matter how ingenious a business model may appear, however, all panelists agreed that the trust of patients remains paramount. Patient trust, then, could well emerge as the ultimate... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based... View Details
Keywords: Martha Lagace
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
care, but there is another cost to be accounted for. Germany May Have the Answer for Reducing Drug PricesIn Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Making Health Insurance... View Details